|
|
|
|
Vol. 16, Issue 11, 5215-5226, November 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




* Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, Montreal, Quebec H2W 1R7, Canada;
Joint Diseases Laboratory, Shriners Hospitals for Children, Montreal, Quebec H3G 1A6, Canada;
Diseases of Aging Program, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario K1Y 4K9, Canada; and
|| Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Submitted June 8, 2005;
Revised August 5, 2005;
Accepted August 23, 2005
Monitoring Editor: Guido Guidotti
The proprotein convertases PC5, PACE4 and furin contain a C-terminal cysteine-rich domain (CRD) of unknown function. We demonstrate that the CRD confers to PC5A and PACE4 properties to bind tissue inhibitors of metalloproteinases (TIMPs) and the cell surface. Confocal microscopy and biochemical analyses revealed that the CRD is essential for cell surface tethering of PC5A and PACE4 and that it colocalizes and coimmunoprecipitates with the full-length and C-terminal domain of TIMP-2. Surface-bound PC5A in TIMP-2 null fibroblasts was only observed upon coexpression with TIMP-2. In COS-1 cells, plasma membrane-associated PC5A can be displaced by heparin, suramin, or heparinases I and III and by competition with excess exogenous TIMP-2. Furthermore, PC5A and TIMP-2 are shown to be colocalized over the surface of enterocytes in the mouse duodenum and jejunum, as well as in liver sinusoids. In conclusion, the CRD of PC5A and PACE4 functions as a cell surface anchor favoring the processing of their cognate surface-anchored substrates, including endothelial lipase.
Abbreviations used: aa, amino acid; Ab, antibody; ConA, concanavalin A; CRD, cysteine-rich domain; EL, endothelial lipase; ECM, extracellular matrix FBS; HSPG, heparan sulfate proteoglycan; MMP, matrix metalloproteinase; PC, proprotein convertase; TIMP-2-LP, TIMP-2-Lamp1 protein; TIMP, tissue inhibitor of metalloproteinase; TM-CT, transmembrane-cytosolic tail; WT, wild type; NT-, N-terminal; CT-, C-terminal.
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).
These authors contributed equally to this work.
Address correspondence to: Nabil G. Seidah (seidahn{at}ircm.qc.ca).
This article has been cited by other articles:
![]() |
R. Essalmani, A. Zaid, J. Marcinkiewicz, A. Chamberland, A. Pasquato, N. G. Seidah, and A. Prat In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate PNAS, April 15, 2008; 105(15): 5750 - 5755. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Poirier, G. Mayer, S. Benjannet, E. Bergeron, J. Marcinkiewicz, N. Nassoury, H. Mayer, J. Nimpf, A. Prat, and N. G. Seidah The Proprotein Convertase PCSK9 Induces the Degradation of Low Density Lipoprotein Receptor (LDLR) and Its Closest Family Members VLDLR and ApoER2 J. Biol. Chem., January 25, 2008; 283(4): 2363 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mayer, J. Hamelin, M.-C. Asselin, A. Pasquato, E. Marcinkiewicz, M. Tang, S. Tabibzadeh, and N. G. Seidah The Regulated Cell Surface Zymogen Activation of the Proprotein Convertase PC5A Directs the Processing of Its Secretory Substrates J. Biol. Chem., January 25, 2008; 283(4): 2373 - 2384. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pullikotil, S. Benjannet, J. Mayne, and N. G. Seidah The Proprotein Convertase SKI-1/S1P: ALTERNATE TRANSLATION AND SUBCELLULAR LOCALIZATION J. Biol. Chem., September 14, 2007; 282(37): 27402 - 27413. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tsuji, H. Kanie, H. Makise, K. Yuasa, M. Nagahama, and Y. Matsuda Engineering of {alpha}1-antitrypsin variants selective for subtilisin-like proprotein convertases PACE4 and PC6: Importance of the P2' residue in stable complex formation of the serpin with proprotein convertase Protein Eng. Des. Sel., April 1, 2007; 20(4): 163 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Benjannet, D. Rhainds, J. Hamelin, N. Nassoury, and N. G. Seidah The Proprotein Convertase (PC) PCSK9 Is Inactivated by Furin and/or PC5/6A: FUNCTIONAL CONSEQUENCES OF NATURAL MUTATIONS AND POST-TRANSLATIONAL MODIFICATIONS J. Biol. Chem., October 13, 2006; 281(41): 30561 - 30572. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Scamuffa, F. Calvo, M. Chretien, N. G. Seidah, and A.-M. Khatib Proprotein convertases: lessons from knockouts FASEB J, October 1, 2006; 20(12): 1954 - 1963. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vigetti, P. Moretto, M. Viola, A. Genasetti, M. Rizzi, E. Karousou, F. Pallotti, G. De Luca, and A. Passi Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging FASEB J, June 1, 2006; 20(8): 1118 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Essalmani, J. Hamelin, J. Marcinkiewicz, A. Chamberland, M. Mbikay, M. Chretien, N. G. Seidah, and A. Prat Deletion of the Gene Encoding Proprotein Convertase 5/6 Causes Early Embryonic Lethality in the Mouse Mol. Cell. Biol., January 1, 2006; 26(1): 354 - 361. [Abstract] [Full Text] [PDF] |
||||